Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique.

[1]  D. Cox.  Regression Models and Life-Tables , 1972 .

[2]  J Roy,et al.  An improved method for computerized tomography-planned transperineal 125iodine prostate implants. , 1991, The Journal of urology.

[3]  C C Ling,et al.  A CT-based evaluation method for permanent implants: application to prostate. , 1993, International journal of radiation oncology, biology, physics.

[4]  J Roy,et al.  Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation. , 1994, International journal of radiation oncology, biology, physics.

[5]  J. Roy,et al.  Short-term freedom from disease progression after I-125 prostate implantation. , 1994, International journal of radiation oncology, biology, physics.

[6]  J. Blasko,et al.  Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma. , 1995, The Journal of urology.

[7]  L. Anderson,et al.  Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .

[8]  R. Stock,et al.  A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. , 1995, International journal of radiation oncology, biology, physics.

[9]  J. Roy,et al.  Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. , 1995, International journal of radiation oncology, biology, physics.

[10]  Y Yu,et al.  A genetic algorithm for the optimization of prostate implants. , 1996, Medical physics.

[11]  J Roy,et al.  Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. Stock,et al.  The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy. , 1997, Seminars in surgical oncology.

[13]  K. Wallner,et al.  CT-based dosimetry for transperineal I-125 prostate brachytherapy. , 1997, International journal of radiation oncology, biology, physics.

[14]  D. Beyer,et al.  Biochemical disease-free survival following 125I prostate implantation. , 1997, International journal of radiation oncology, biology, physics.

[15]  M. Zelefsky,et al.  Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer. , 1997, The Journal of urology.

[16]  L E Reinstein,et al.  A new genetic algorithm technique in optimization of permanent 125I prostate implants. , 1998, Medical physics.

[17]  J J Prete,et al.  Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[18]  H. Ragde,et al.  Ten‐year disease free survival after transperineal sonography‐guided iodine‐125 brachytherapy with or without 45‐gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma , 1999, Cancer.

[19]  W. Butler,et al.  Potential role of various dosimetric quality indicators in prostate brachytherapy. , 1999, International journal of radiation oncology, biology, physics.

[20]  Michael J. Zelefsky,et al.  Comparison of the 5-Year Outcome and Morbidity of Three-Dimensional Conformal Radiotherapy Versus Transperineal Permanent Iodine-125 Implantation for Early-Stage Prostatic Cancer , 1999 .

[21]  G. Gustafson,et al.  Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants. , 1999, International journal of radiation oncology, biology, physics.

[22]  P. Okunieff,et al.  Automated treatment planning engine for prostate seed implant brachytherapy. , 1999, International journal of radiation oncology, biology, physics.

[23]  P. Grimm,et al.  American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. , 1999, International journal of radiation oncology, biology, physics.